Abstract:The process of induced pluripotent stem cells (iPSCs) reprogramming involves several crucial events, including the mesenchymal-epithelial transition (MET), activation of pluripotent genes, metabolic reprogramming, and epigenetic rewiring. Although these events intricately interact and influence each other, the specific element that regulates the reprogramming network remains unclear. Dux, a factor known to promote totipotency during the transition from embryonic stem cells (ESC) to 2C-like ESC (2CLC), has not been extensively studied in the context of iPSC reprogramming. In this study, we demonstrate that the modification of H3K18la induced by Dux overexpression controls the metabolism-H3K18la-MET network, enhancing the efficiency of iPSC reprogramming through a metabolic switch and the recruitment of p300 via its C-terminal domain. Furthermore, our proteomic analysis of H3K18la immunoprecipitation experiment uncovers the specific recruitment of Brg1 during reprogramming, with both H3K18la and Brg1 being enriched on the promoters of genes associated with pluripotency and epithelial junction. In summary, our study has demonstrated the significant role of Dux-induced H3K18la in the early reprogramming process, highlighting its function as a potent trigger. Additionally, our research has revealed, for the first time, the binding of Brg1 to H3K18la, indicating its role as a reader of histone lactylation.

What problem does this paper attempt to address?

The paper primarily explores the role of the Dux protein in the reprogramming process of induced pluripotent stem cells (iPSCs), particularly how it promotes metabolic reprogramming and the activation of the mesenchymal-epithelial transition (MET) network by regulating histone lactylation modification (H3K18la). The study found that Dux overexpression can enhance iPSC reprogramming efficiency and revealed the critical role of histone H3 lysine 18 lactylation (H3K18la) in this process. Specifically, Dux promotes the metabolic switch from oxidative phosphorylation to glycolysis (OGS) and recruits the p300 enzyme via its C-terminus to increase H3K18la levels. Additionally, the study identified Brg1 as a "reader" of H3K18la, a protein that recognizes this histone modification, thereby further promoting the reprogramming process. In summary, the paper aims to address the following questions: 1. Explore the mechanism of Dux in the early stages of iPSC reprogramming. 2. Elucidate how Dux affects iPSC reprogramming efficiency by regulating histone lactylation (H3K18la). 3. Reveal the function of Brg1 as a reader of H3K18la and its impact on reprogramming.

Dux activates metabolism-lactylation-MET network during early iPSC reprogramming with Brg1 as the histone lactylation reader